Serpin Pharma Joins Prince William Science Accelerator
Monday, September 12, 2016
Serpin Pharma, LLC, a development stage biotech company, just leased a total of 1,141 square feet at the Prince William Science Accelerator wet lab facility. Their addition to the wet lab facility, only leaves one more available space for lease in the facility.
“We are happy to be located in such a state-of-the-art facility as the Prince William Science Accelerator,” said Dr. Cohava Gelber, Founder and Executive Chairperson of Serpin Pharma, LLC. “Being in the heart of Innovation Park, within close proximity to Mason’s Science and Technology Campus and related research institutions will only enhance our work going forward,” he added.
“Serpin Pharma, LLC has been a welcome addition to our roster of life sciences companies at the Prince William Science Accelerator,” said Jeffrey Kaczmarek, Executive Director, Prince William County Department of Economic Development. “The groundbreaking work being carried out by Serpin Pharma, LLC is consistent with and reflective of the caliber of companies we expected to attract when we embarked on the establishment of the Science Accelerator,” he added.
Established in 2011, Serpin Pharma, LLC specializes in the development of anti-inflammatory and immune modulating peptides with potential application in inflammatory, autoimmune diseases such as rheumatoid arthritis and diabetes. The company has been awarded over $500,000 in sought-after Small Business Innovation Research (SBIR) grants from the National Institutes of Health and the Commonwealth of Virginia. The company already holds a patent and has applied for additional patents to cover “use” and “composition-of-matter” for a family of anti-inflammatory peptides.